Article
Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
Journal of molecular biology - 2 Nov 2001
Sayre P H, Finer-Moore J S, Fritz T A, Biermann D, Gates S B, MacKellar W C, Patel V F, Stroud R M
Abstract excerpt
Crystal structures of four pyrrolo(2,3-d)pyrimidine-based antifolate compounds, developed as inhibitors of thymidylate synthase (TS) in a strategy to circumvent drug-resistance, have been determined in complexes with their in vivo target, human thymidylate synthase, and with the structurally best-characterized Escherichia coli enzyme, to resolutions of 2.2-3.0 A. The 2.9 A crystal structure of a complex of human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
